Baxter Announces CEO Retirement and Appointment of COO

BAXTER ANNOUNCES CEO RETIREMENT AND APPOINTMENT OF COO

José (Joe) E. Almeida to retire as Chair, President and Chief Executive Officer DEERFIELD, Ill., FEB. 3, 2025 – Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that José (Joe) E. Almeida, chair, president and chief executive officer (CEO), will retire from his executive roles with the company, effective immediately. He will serve in an advisory capacity through Oct. 31, 2025. The Baxter … Continue reading BAXTER ANNOUNCES CEO RETIREMENT AND APPOINTMENT OF COO

Lingraphica

Lingraphica Announces Leadership Transition: Kevin Self to Succeed Andrew Gomory as CEO

Press Release – PRINCETON, N.J. – Lingraphica, a leader in augmentative and alternative communication (AAC) devices, announced a significant leadership transition. Current Chief Operating Officer Kevin Self has assumed the role of Chief Executive Officer effective January 1, 2025. He succeeds Andrew Gomory, a visionary leader who has retired after over two decades of driving the company’s innovation and expanding its industry presence, while continuing … Continue reading Lingraphica Announces Leadership Transition: Kevin Self to Succeed Andrew Gomory as CEO

Topcon Healthcare

Jacques Gilbert Appointed Chief Strategy and Business Development Officer at Topcon Healthcare, Inc.

Press Release – December 19, 2024 – OAKLAND, N.J. – Topcon Healthcare, Inc., a leading provider of medical devices and digital healthcare solutions, is pleased to announce the appointment of Jacques Gilbert as Chief Strategy and Business Development Officer. In this pivotal role, Jacques will lead the development and execution of Topcon Healthcare’s business strategy, focusing on the company’s groundbreaking Healthcare from the Eye™ initiative—a connected care ecosystem using oculomics, … Continue reading Jacques Gilbert Appointed Chief Strategy and Business Development Officer at Topcon Healthcare, Inc.

Imbed Biosciences

Imbed Biosciences Appoints Bristol Myers Squibb Veteran Terry Bromley as Chief Executive Officer

Press Release – December 19, 2024 – MIDDLETON, Wis. – Imbed Biosciences today announced that Terry Bromley has joined as Chief Executive Officer. With over 30 years of experience in the medical device, regenerative medicine and wound and skin markets, Mr. Bromley will be instrumental in fostering the company’s growth and continue Imbed Biosciences’ mission to transform the future of soft tissue repair through advanced … Continue reading Imbed Biosciences Appoints Bristol Myers Squibb Veteran Terry Bromley as Chief Executive Officer

dexcom

Dexcom Launches the First Generative AI Platform in Glucose Biosensing

Press Release – December 17, 2024 – SAN DIEGO – DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today it has launched a proprietary Generative AI (GenAI) platform, making Dexcom the first CGM manufacturer to integrate GenAI into glucose biosensing technology.1 The new Dexcom GenAI platform will analyze individual health data patterns to reveal a direct association between lifestyle choices and glucose levels while providing … Continue reading Dexcom Launches the First Generative AI Platform in Glucose Biosensing